Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ami Miller

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Scientific Reports|May 20, 2021
A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infectionAmi Miller, Adam Leach, Jemima Thomas, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2019
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compoundsAbimael Cruz-Migoni, Peter Canning, Camilo E Quevedo, et al.
Scientific Reports|December 6, 2017
Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF proteinLeyuan Bao, Clare Hannon, Abimael Cruz-Mignoni, et al.
Nature Communications|June 15, 2019
KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobeNicolas Bery, Sandrine Legg, Judit Debreczeni, et al.
Nature Communications|August 11, 2018
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragmentCamilo E Quevedo, Abimael Cruz-Migoni, Nicolas Bery, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Scientific Reports|May 20, 2021
A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infectionAmi Miller, Adam Leach, Jemima Thomas, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2019
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compoundsAbimael Cruz-Migoni, Peter Canning, Camilo E Quevedo, et al.
Scientific Reports|December 6, 2017
Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF proteinLeyuan Bao, Clare Hannon, Abimael Cruz-Mignoni, et al.
Nature Communications|June 15, 2019
KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobeNicolas Bery, Sandrine Legg, Judit Debreczeni, et al.
Nature Communications|August 11, 2018
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragmentCamilo E Quevedo, Abimael Cruz-Migoni, Nicolas Bery, et al.
Pageof 3